FDA continues crackdown on marketers of bogus flu remedies


Federal health officials have warned nine more makers of dietary supplements that they are in violation of federal laws for marketing products to combat the flu virus.

According to a Reuters report, the Food and Drug Administration has warned these companies via letters that were sent directly to them and posted on the agency’s Web site. The FDA says that these nine companies are marketing over-the-counter herbal flu remedies that they claim can shorten the duration and lessen the severity of the flu virus.

This is the latest string of warnings to come from federal regulators warning about the presence of herbal remedies that purportedly can combat the flu. In the U.S. this year, the flu virus has been particularly potent and many cases of the virus have been severe. At some point during the winter flu season, nearly every state in the U.S. had reported widespread outbreaks of the flu. This has increased demand for flu relief products.

The FDA takes exception to products that make medical claims on labeling or in marketing materials. Warning letters address these claims and order companies to halt any mention of an herbal supplement having the ability to reduce symptoms of the flu.

Among the products made by companies who received warning letters are Resveratrol, Garlic, Echinacea, Elderberry, Ashwagandha, and Astragalus Immune System Support.